Riskpilot← Back to searchSign inGet full accessMatherian Pharmacy AB
ABActiveOrg 5591902423Nedre Långvinkelsgatan 19Retail sale of pharmaceutical products · NACE 4773Est. 20190 employees
Revenue 2024
SEK 0
EBITDA margin
—
-53% vs 2023
Equity ratio
94.5%
Financial strength
Net profit 2024
SEK 15K
+137% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -64K | -53% |
| Net profit | SEK 15K | +137% |
| Total assets | SEK 767K | -8% |
| Equity | SEK 725K | +2% |
| Employees | 0 | — |
Legal name
Matherian Pharmacy AB
Org number
5591902423
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
8 januari 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva detaljhandel (apotek), försäljning och distribution av läkemedel och kroppsnära-, sjukvårdsnära- och hälsoprodukter samt information och tillhandahållande av sjukvårdstjänster. Uthyrning av personal. Läkemedel och kroppsnära, sjukvårdsnära och hälsoprodukter. Uthyrning av personal.
Address
Nedre Långvinkelsgatan 19
Email
wolfgang.handl@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 608 | 545 | 706 | 130 | 0 |
| Staff expenses | — | — | −293 | −14 | −0 |
| EBITDA | 281 | 188 | 307 | −42 | −64 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 281 | 188 | 307 | −42 | −64 |
| Net financials | — | — | 0 | −0 | 0 |
| Profit before tax | 216 | 142 | 307 | −42 | 15 |
| Tax | −47 | −30 | −64 | — | — |
| Net profit | 169 | 112 | 243 | −42 | 15 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 703 | 792 | 1 015 | 830 | 767 |
| Equity | 446 | 558 | 751 | 709 | 725 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 191 | 123 | 152 | 10 | 10 |
| Total debt | 191 | 123 | 152 | 10 | 10 |
EBITDA margin
-6358400.0%
This company
15.8%
Market median
-40243138% vs market
20202024
Equity ratio
94.5%
This company
38.2%
Market median
+147% vs market
20202024
Return on equity
2.1%
This company
18.4%
Market median
-89% vs market
20202024
Net profit margin
1549700.0%
This company
8.1%
Market median
+19131999% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
WH Chief Executive Officer | Chief Executive Officer | 2025 |
KR Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Former (1) | ||
MT Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Matherian Pharmacy AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Wolfgang Helmut Handl | Chief Executive Officer | 0 companies |
| Karl Richard Handl | Deputy Chief Executive Officer | 0 companies |
| Marie Therese Handl | Chief Executive Officer | 0 companies |
| Anicka Muzinic | Deputy Board Member | 0 companies |